Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol-salicylate derivatives as selective DNMT3 inhibitors and anticancer agents
Fahad S. Aldawsari, Rodrigo Aguayo‐Ortiz, Kanishk Kapilashrami, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2015) Vol. 31, Iss. 5, pp. 695-703
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge
Omar Castillo‐Aguilera, Patrick Depreux, Ludovic Halby, et al.
Biomolecules (2017) Vol. 7, Iss. 1, pp. 3-3
Open Access | Times Cited: 141
Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway
Hossein Hosseini, Maryam Teimouri, Maryam Shabani, et al.
The International Journal of Biochemistry & Cell Biology (2019) Vol. 119, pp. 105667-105667
Closed Access | Times Cited: 122
Strategies to Improve Resveratrol Systemic and Topical Bioavailability: An Update
Sebastiano Intagliata, Maria Modica, Ludovica Maria Santagati, et al.
Antioxidants (2019) Vol. 8, Iss. 8, pp. 244-244
Open Access | Times Cited: 115
Cancer Chemoprevention by Phytochemicals: Nature’s Healing Touch
Haseeb Zubair, Shafquat Azim, Aamir Ahmad, et al.
Molecules (2017) Vol. 22, Iss. 3, pp. 395-395
Open Access | Times Cited: 104
Epigenetic modification of Nrf2 by sulforaphane increases the antioxidative and anti-inflammatory capacity in a cellular model of Alzheimer's disease
Fangfang Zhao, Jianlei Zhang, Na Chang
European Journal of Pharmacology (2018) Vol. 824, pp. 1-10
Closed Access | Times Cited: 104
Resveratrol – A comprehensive review of recent advances in anticancer drug design and development
Reza Ahmadi, Mohammad Ali Ebrahimzadeh
European Journal of Medicinal Chemistry (2020) Vol. 200, pp. 112356-112356
Closed Access | Times Cited: 94
Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer
Wei Qiu, Jun Lin, Yichen Zhu, et al.
Cellular Physiology and Biochemistry (2017) Vol. 41, Iss. 4, pp. 1325-1335
Open Access | Times Cited: 70
Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy
Ting Chen, Syrine Mahdadi, Michel Vidal, et al.
Pharmacological Research (2024) Vol. 207, pp. 107328-107328
Open Access | Times Cited: 8
Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation
Dimitry A. Chistiakov, Alexander N. Orekhov, Yuri V. Bobryshev
International Journal of Cardiology (2016) Vol. 227, pp. 66-82
Closed Access | Times Cited: 55
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
Sheng F. Cai, Chun‐Wei Chen, Scott A. Armstrong
Molecular Cell (2015) Vol. 60, Iss. 4, pp. 561-570
Open Access | Times Cited: 48
An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs
Deyu Huang, Luqing Cui, Saeed Ahmed, et al.
Food and Chemical Toxicology (2018) Vol. 123, pp. 574-594
Closed Access | Times Cited: 41
DNMT3Bin vitroknocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation
Francesca Megiorni, Simona Camero, Simona Ceccarelli, et al.
Oncotarget (2016) Vol. 7, Iss. 48, pp. 79342-79356
Open Access | Times Cited: 39
Resveratrol ameliorates atherosclerosis induced by high-fat diet and LPS in ApoE−/− mice and inhibits the activation of CD4+ T cells
Liyu Zhou, Jun Long, Yuting Sun, et al.
Nutrition & Metabolism (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 38
Natural Product-Based Hybrids as Potential Candidates for the Treatment of Cancer: Focus on Curcumin and Resveratrol
Nicola Micale, Maria Sofia Molonia, Andrea Citarella, et al.
Molecules (2021) Vol. 26, Iss. 15, pp. 4665-4665
Open Access | Times Cited: 31
Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases
Hui Xu, Shuang Li, You‐Shuo Liu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 30
Mechanisms of Phytoremediation by Resveratrol against Cadmium Toxicity
Barbara Mognetti, Francesco Franco, Chiara Castrignano, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 782-782
Open Access | Times Cited: 4
Epidrugs in the clinical management of atherosclerosis: Mechanisms, challenges and promises
Sushma Panduga, Sampara Vasishta, Ramamoorthy Subramani, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176827-176827
Open Access | Times Cited: 4
Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth
Chao‐Cheng Cho, Chun-Jung Lin, Hsun-Ho Huang, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 6, pp. 1335-1350
Open Access | Times Cited: 10
Epigenetic Alterations in Cancer: The Therapeutic Potential of Epigenetic Drugs in Cancer Therapy
Preeti Gupta
Drugs and Drug Candidates (2025) Vol. 4, Iss. 2, pp. 15-15
Open Access
The Impact of Environmental Factors in Influencing Epigenetics Related to Oxidative States in the Cardiovascular System
Francesco Angelini, Francesca Pagano, Antonella Bordin, et al.
Oxidative Medicine and Cellular Longevity (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 33
Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification
Qingshan Li, Yao Li, Girdhar Singh Deora, et al.
Mini-Reviews in Medicinal Chemistry (2019) Vol. 19, Iss. 10, pp. 809-825
Closed Access | Times Cited: 29
Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches
Jelica Vučićević, Katarina Nikolić, John B. O. Mitchell
Current Medicinal Chemistry (2019) Vol. 26, Iss. 21, pp. 3874-3889
Open Access | Times Cited: 28
Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs
Mohamed Salla, Vrajesh Pandya, Khushwant S. Bhullar, et al.
Molecules (2020) Vol. 25, Iss. 17, pp. 3849-3849
Open Access | Times Cited: 25
Fruit Extract, Rich in Polyphenols and Flavonoids, Modifies the Expression of DNMT and HDAC Genes Involved in Epigenetic Processes
Ghodratollah Nowrasteh, Afshin Zand, Bence L. Raposa, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1867-1867
Open Access | Times Cited: 9
Potential Epigenetic Modifiers Targeting the Alteration of Methylation in Colorectal Cancer
Abdeslam Jaafari
Gene Expression (2024) Vol. 23, Iss. 2, pp. 139-152
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top